Meningeal Dose of Ceftriaxone
For adults with bacterial meningitis, administer ceftriaxone 2 g IV every 12 hours (total 4 g/day); for children, administer 100 mg/kg/day IV (maximum 4 g/day) either as a single daily dose or divided every 12 hours.
Adult Dosing
The standard meningeal dose for adults is ceftriaxone 2 g IV every 12 hours 1. This can alternatively be given as 4 g IV once daily 2, though the twice-daily regimen is more commonly recommended in guidelines. The total daily dose should not exceed 4 grams 3.
- Empiric therapy: Start immediately with 2 g IV every 12 hours for all adults under 60 years 1
- Confirmed pneumococcal or meningococcal meningitis: Continue 2 g IV every 12 hours 1
- Duration: 10-14 days for pneumococcal meningitis (10 days if stable by day 10, extend to 14 days if slower response); 5 days for meningococcal meningitis 1
Important Considerations for Adults
When penicillin-resistant pneumococci are suspected (e.g., recent travel to high-resistance areas), add vancomycin 15-20 mg/kg IV every 12 hours OR rifampicin 600 mg every 12 hours to the ceftriaxone regimen 1. For patients ≥60 years, also add amoxicillin 2 g IV every 4 hours to cover Listeria monocytogenes 1.
Recent research suggests that once susceptibilities confirm penicillin-susceptible S. pneumoniae, a reduced dose of 2 g once daily (total 2 g/day) may be adequate 4, though this contradicts guideline recommendations and should only be considered after pathogen identification and susceptibility confirmation.
Pediatric Dosing
For bacterial meningitis in children, the recommended dose is 100 mg/kg/day IV (maximum 4 g/day) 2, 3. This can be administered either:
- Once daily (100 mg/kg, max 4 g), OR
- Divided every 12 hours (50 mg/kg every 12 hours, max 2 g per dose)
Age-Specific Pediatric Recommendations
Children 1 month to 18 years:
- Initial dose: 100 mg/kg IV (not to exceed 4 g)
- Maintenance: 100 mg/kg/day (not to exceed 4 g daily), given once daily or divided every 12 hours 2
- Duration: 7-14 days 3
Neonates (≤28 days):
- Ceftriaxone is contraindicated in premature neonates 3
- Ceftriaxone is contraindicated in term neonates receiving or expected to receive calcium-containing IV solutions 3
- If used in eligible neonates, infuse over 60 minutes (not 30 minutes) to reduce risk of bilirubin encephalopathy 3
- Hyperbilirubinemic neonates should not receive ceftriaxone 3
Once Daily vs. Twice Daily in Children
Recent pharmacokinetic modeling suggests that once-daily dosing (100 mg/kg) achieves superior CSF penetration compared to twice-daily dosing (50 mg/kg every 12 hours) 5. The once-daily regimen achieved 88% probability of target attainment at 24 hours versus 53% for twice-daily dosing, though both achieved 100% at steady state 5. This supports using the 100 mg/kg once-daily regimen for empirical treatment to achieve pharmacodynamic targets earlier.
Administration Guidelines
- Infusion time: 30 minutes for adults and children (except neonates) 3
- Infusion time for neonates: 60 minutes to reduce bilirubin encephalopathy risk 3
- Concentration: 10-40 mg/mL recommended 3
Critical Safety Warning
Never mix ceftriaxone with calcium-containing solutions (Ringer's, Hartmann's, calcium-containing parenteral nutrition) due to precipitation risk 3. In patients other than neonates, ceftriaxone and calcium-containing solutions may be given sequentially only if IV lines are thoroughly flushed between infusions 3.
Common Pitfalls
Underdosing in renal impairment: No dose adjustment is needed for renal or hepatic impairment up to 2 g/day 3. However, recent data suggests high-dose regimens (4 g/day) should be adjusted based on estimated GFR to avoid both underdosing and toxicity 6.
Premature dose reduction: Many clinicians reduce from twice-daily to once-daily dosing after 1-2 days 4, but this should only occur after pathogen identification and confirmed susceptibility, not empirically.
Inadequate coverage for S. aureus: Neither standard dosing regimen achieves adequate CSF concentrations for S. aureus meningitis (MIC 4 mg/L) 5. Add vancomycin if S. aureus is suspected or confirmed.
Neonatal administration errors: Failure to extend infusion time to 60 minutes in neonates or administering to hyperbilirubinemic infants can cause serious complications 3.